FDA 510(k)

EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone )

K-Number: K243609 · 2024-12-18

Decision Date2024-12-18

Product CodeMQV

Advisory CommitteeOR

DecisionSubstantially Equivalent

Device Summary

EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone ) is the device name listed in this FDA 510(k) record. The listed applicant is Etex Corporation. It received FDA 510(k) clearance on 2024-12-18 under 510(k) number K243609. The device is classified under product code MQV. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone )?

EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone ) is a medical device that received FDA 510(k) clearance on 2024-12-18. The listed applicant is Etex Corporation. The 510(k) number is K243609.

When did EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone ) receive FDA 510(k) clearance?

EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone ) received FDA 510(k) clearance on 2024-12-18, under 510(k) number K243609.

Who is the listed applicant for EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone )?

The FDA 510(k) record lists Etex Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone )?

The FDA product code for EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone ) is MQV.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT01234415Bone Substitute in the Multi Traumatized Nasal Septum ReconstructionCOMPLETED NCT05706909The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral HeadACTIVE_NOT_RECRUITING NCT07057817The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb SalvageRECRUITING NCT07059065FIBERGRAFT Aeridyan Posterolateral Fusion StudyRECRUITING NCT07500961Novel Bone Substitute (ALBO-OS) in Patients With Periodontal Disease or Who Need Alveolar PreservationACTIVE_NOT_RECRUITING NCT07569146Assessment of Deproteinized Bovine Bone for Immediate Implants Placement in Maxillary Esthetic Zone.COMPLETED

Other records listing Etex Corporation as applicant

K182107CarriGen PF

Related Devices (Code: MQV)

K260364Device 300419 StripGeistlich Pharma AG K252797JAZBI™ Resorbable Bone Void FillerSdip Innovations Pty, Ltd.K261008Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip; Vitoss® BiModal Bioactive Bone Graft Substitute; Vitoss BBTrauma® Bioactive Bone Graft Substitute; Vitoss® BA2X Bioactive Bone Graft Substitute; Vitoss® Bioactive Foam Bone Graft Substitute Pack; Vitoss® Bioactive Foam Bone Graft Substitute; Vitoss® Foam Bone Graft Substitute; Vitoss® Bone Graft Substitute Filled Canister; Vitoss® Bone Graft SubstituteStryker Spine K253524Adaptos®Fuse Bone GraftBiomendex OY K253147FIBERGRAFT™ BG Putty GPS Bone Graft Substitute FIBERGRAFT™ BG Putty Bone Graft Substitute FIBERGRAFT™ AERIDYAN™ Matrix Bone Graft Substitute FIBERGRAFT™ BG Matrix Bone Graft SubstituteProsidyan, Inc.K251522Mg OSTEOINJECT™; Mg OSTEOREVIVE™; Mg OSTEOCRETE™Bone Solutions, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.